Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.45
-0.05 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
7.60
+0.15 (2.01%)
After-hours: Apr 28, 2026, 6:59 PM EDT
Solid Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | - | - | 8.09 | 13.62 | |
| Revenue Growth (YoY) | - | - | - | -40.57% | - | |
| Cost of Revenue | - | - | - | 78.42 | 58.74 | |
| Gross Profit | - | - | - | -70.33 | -45.12 | |
| Selling, General & Admin | 38.88 | 33.3 | 27.75 | 24.08 | 27.14 | |
| Research & Development | 140.33 | 96.43 | 76.56 | - | - | |
| Operating Expenses | 179.21 | 129.73 | 104.32 | 24.08 | 27.14 | |
| Operating Income | -179.21 | -129.73 | -104.32 | -94.4 | -72.25 | |
| Interest Expense | - | -0.34 | -0.44 | - | - | |
| Interest & Investment Income | 9.9 | 9.47 | 7.58 | 2.62 | 0.06 | |
| Other Non Operating Income (Expenses) | -5.02 | -4.1 | 1.1 | -0.38 | 0 | |
| EBT Excluding Unusual Items | -174.33 | -124.7 | -96.08 | -92.17 | -72.19 | |
| Merger & Restructuring Charges | - | - | 0.06 | -12.05 | - | |
| Other Unusual Items | - | - | - | 18.24 | - | |
| Pretax Income | -174.33 | -124.7 | -96.02 | -85.98 | -72.19 | |
| Earnings From Continuing Operations | -174.33 | -124.7 | -96.02 | -85.98 | -72.19 | |
| Net Income | -174.33 | -124.7 | -96.02 | -85.98 | -72.19 | |
| Net Income to Common | -174.33 | -124.7 | -96.02 | -85.98 | -72.19 | |
| Shares Outstanding (Basic) | 88 | 41 | 20 | 9 | 7 | |
| Shares Outstanding (Diluted) | 88 | 41 | 20 | 9 | 7 | |
| Shares Change (YoY) | 114.38% | 105.27% | 133.60% | 19.59% | 105.58% | |
| EPS (Basic) | -1.99 | -3.06 | -4.83 | -10.10 | -10.14 | |
| EPS (Diluted) | -1.99 | -3.06 | -4.83 | -10.10 | -10.14 | |
| Free Cash Flow | -157.44 | -100.67 | -95.7 | -100.99 | -79.05 | |
| Free Cash Flow Per Share | -1.80 | -2.47 | -4.81 | -11.87 | -11.11 | |
| Operating Margin | - | - | - | -1166.35% | -530.50% | |
| Profit Margin | - | - | - | -1062.28% | -530.01% | |
| Free Cash Flow Margin | - | - | - | -1247.74% | -580.36% | |
| EBITDA | -177.57 | -127.27 | -101.73 | -92 | -69.29 | |
| D&A For EBITDA | 1.64 | 2.46 | 2.58 | 2.41 | 2.96 | |
| EBIT | -179.21 | -129.73 | -104.32 | -94.4 | -72.25 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.